SRE Holdings (2980) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Sep, 2025Executive summary
Net sales for the nine months ended December 31, 2024, rose 12.6% year-over-year to ¥14,413 million, while operating profit declined 4.4% to ¥1,444 million and ordinary profit fell 6.7% to ¥1,300 million.
Profit attributable to owners of parent dropped 31.7% year-over-year to ¥636 million, with basic EPS at ¥39.59, down from ¥57.64 in the prior year.
Comprehensive income decreased 24.4% year-over-year to ¥739 million.
Financial highlights
Gross profit increased to ¥6,331 million from ¥5,240 million year-over-year, but selling, general, and administrative expenses rose to ¥4,887 million.
Total assets grew to ¥33,220 million as of December 31, 2024, up from ¥24,017 million at the previous fiscal year-end.
Equity ratio declined to 37.8% from 50.6% at the previous fiscal year-end.
Net assets increased to ¥13,240 million from ¥12,460 million.
Outlook and guidance
Full-year forecast for FYE March 31, 2025: net sales of ¥27,000 million (up 11.5% year-over-year), operating profit of ¥3,050 million (up 37.9%), ordinary profit of ¥2,900 million (up 40.9%), and profit attributable to owners of parent of ¥1,850 million (up 33.2%).
Basic profit per share forecasted at ¥114.57 for the full year.
No dividend is planned for the fiscal year.
Latest events from SRE Holdings
- Record profit and revenue growth driven by AI and real estate, with strong outlook.2980
Q3 202610 Feb 2026 - Profits fell sharply, but AI and healthcare segments grew; strong 2H recovery expected.2980
Q2 202611 Nov 2025 - Sales declined and a net loss was posted, but AI Cloud & Consulting showed strong growth.2980
Q1 20268 Sep 2025 - Strong sales and profit growth driven by segment expansion and Medix acquisition.2980
Q1 20258 Sep 2025 - Double-digit sales and profit growth, boosted by Medix acquisition and segment expansion.2980
Q2 20258 Sep 2025 - Strong revenue and profit growth with FY2026 guidance projecting over 30% increases.2980
Q4 20258 Sep 2025